| Date Filed | Type | Description |
| 08/21/2023 |
3
| Renondin Jean-Christophe (Director) has filed a Form 3 on AgeX Therapeutics, Inc. |
| 05/18/2023 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 756,429 options to buy
@ $0.661, valued at
$500k
|
|
| 03/22/2023 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Gifted 16,447,500 shares
@ $0 |
|
| 03/22/2023 |
3
| Juvenescence US Corp. (10% Owner) has filed a Form 3 on AgeX Therapeutics, Inc. |
| 03/14/2023 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,060 shares
@ $0.59, valued at
$625.4
Exercised 3,125 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,081 shares
@ $0.5623, valued at
$607.8
Exercised 3,125 restricted stock units
@ $0 |
|
| 08/24/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 746,380 options to buy
@ $0.6699, valued at
$500k
|
|
| 08/24/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 703,234 options to buy
@ $0.711, valued at
$500k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 568,440 options to buy
@ $0.8796, valued at
$500k
|
|
| 03/15/2022 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,281 shares
@ $0.6923, valued at
$886.8
Exercised 3,125 restricted stock units
@ $0 |
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2022 |
3
| Hackett Joanne M. (Director) has filed a Form 3 on AgeX Therapeutics, Inc. |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| MALIK NAFEES NASEER (COO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.45, valued at
$108.8k
|
|
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,081 shares
@ $1.69, valued at
$1.8k
Exercised 3,125 restricted stock units
@ $0 |
|
|